Figure 1  :  Shows typical 'metronomic' chemotherapies in comparison to the standard procedure (repetitive infusions or boli near resp. at the MTD) from [6]. From above to below:
1st row figures a classical q3w schedule at the MTD;
2nd row shows a continuous infusion at the MTD;
3rd row presents a metronomic (daily) oral therapy;
4th row displays a continuous infusion together with a q3w application of iv chemotherapy (e.g. ECF);
5th row depicts a q3w iv chemotherapy combined with a metronomic low – dose concept (e.g. XELOX)
6th row shows a weekly chemotherapy (e.g. Paclitaxel)

Klaus et al.Journal of Cancer Therapeutics and Research  2012 1:32DOI : 10.7243/2049-7962-1-32